mouse |
LD50 |
intramuscular |
1800mg/kg (1800mg/kg) |
|
Therapie. Vol. 16, Pg. 136, 1961. |
mouse |
LD50 |
intraperitoneal |
750mg/kg (750mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Bollettino Chimico Farmaceutico. Vol. 97, Pg. 608, 1958. |
mouse |
LD50 |
intravenous |
235mg/kg (235mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 109, 1963. |
mouse |
LD50 |
oral |
1700mg/kg (1700mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 109, 1963. |
mouse |
LD50 |
subcutaneous |
1330mg/kg (1330mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 109, 1963. |
rat |
LD50 |
intraperitoneal |
840mg/kg (840mg/kg) |
|
Therapie. Vol. 16, Pg. 136, 1961. |